Posts Tagged: Kyle Bass


An entirely screwed up way of viewing the world of innovation

When a product or process worth stealing is created the party that is considered the innovator is the thief and the party that is considered to be …
By Steve Brachmann & Gene Quinn
11 months ago 13

PTAB ends Kyle Bass IPRs targeting Acorda patents on Ampyra MS treatment with no findings of obviousness

A panel of administrative patent judges (APJs) at the Patent Trial and Appeal Board (PTAB) issued a final written decision ending a series of inter partes review (…
By Steve Brachmann
11 months ago 2

What is Michelle Lee Hiding?

Michelle Lee talks about transparency, but the PTO is hiding behind redacted pages and claims of privilege to deny a legitimate FOIA request from Kyle Bass. “I …
By Erich Spangenberg
2 years ago 39

The Year in Patents: The Top 10 Patent Stories from 2015

It is that time once again when we look back on the previous year in preparation to close the final chapter in order move fresh into the …
By Gene Quinn
2 years ago 0

PTAB Hedge Fund Failures Diffuse Early Market Hysteria

The early “death squad” hysteria persisted just long enough to catch the interest of hedge funds. The hedge funds saw an opportunity to utilize the PTAB to …
By Scott A. McKeown
2 years ago 0

Kyle Bass IPR challenge moves foward, what does it mean for patent reform?

The first bit of good news for Bass came with respect to his IPR petition against Celgene Corporation. Celgene Corporation filed a motion for sanctions against the …
By Gene Quinn
2 years ago 5

Fat cats have the patent system perpetually on the brink

The stark reality of how government operates leaves us with a patent system that will be perpetually on the brink. Giant corporations have become effectively insulated from …
By Gene Quinn
2 years ago 31

Inter Partes Review and the Controversial Implications of the Kyle Bass Petitions

I will moderate what should be a lively discussion on the PTAB and inter partes review. I will be joined by Erich Spangenberg, advisor to Kyle Bass …
By Gene Quinn
2 years ago 9

With dubious logic and inaccurate statements of law, PTAB denies another Kyle Bass IPR petition

The PTAB said that the full pilot study had not been made of record, which apparently also meant to the Board that the available description of the …
By Gene Quinn
2 years ago 1

USPTO denies Kyle Bass IPR patent challenge against Acorda Therapeutics

The USPTO declined to initiate an inter partes review of two patents owned by Acorda Therapeutics, Inc. Acorda patents were challenged by the Coalition for Affordable Drugs, …
By Gene Quinn
2 years ago 5

PTAB to determine whether to sanction Kyle Bass for filing IPRs

According to Celgene, the Kyle Bass strategy of shorting a stock and filing an inter partes review challenge is an abuse of the process and not what …
By Gene Quinn
3 years ago 31

It’s Time to Whack ‘IPR Trolls’

Having to defend their patent in post grant reviews such as an IPR can easily cost patent owners between $700,000 to over $1 million when the subject matter of …
By Joseph Allen
3 years ago 25

Patent Reform 101 – A Primer on Pending Patent Legislation

Patent reform is the new normal and we can expect that it will continually be raised in every new Congress for the foreseeable future. Currently there are …
By Gene Quinn
3 years ago 2

Mixed Reviews for the PATENT Act in the Senate

Microsoft applauded the introduction of the PATENT Act. Universities seem to be on the fence, recognizing that the Senate alternative is an improvement, but likely to support …
By Gene Quinn
3 years ago 8

Patent Reform Advances on Capitol Hill

Yesterday the House Committee on Energy and Commerce voted to approve the Targeting Rogue and Opaque Letters (TROL) Act by a vote of 30-22. Meanwhile, the Protecting …
By Gene Quinn
3 years ago 7